GlassScriptPhysician profile
Maya Mehta
NPI 1972759603
$789.59
in general payments reported to CMS, 2019-2025
18 companies · $18.40 in 2025
The $18.40 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $344 · 2022: $146 · 2023: $150 · 2024: $132 · 2025: $18.40.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $300.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $300.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $194.75 | 2021-2024 | Rybelsus, Ozempic |
| Takeda Pharmaceuticals U.S.A., INC. | $118.75 | 2021-2022 | |
| Lilly USA, LLC | $64.03 | 2021 | |
| Abbvie INC. | $61.97 | 2023 | |
| Astrazeneca Pharmaceuticals LP | $53.69 | 2022-2023 | Breztri |
| Boehringer Ingelheim Pharmaceuticals, INC. | $38.13 | 2021-2022 | |
| Exact Sciences Corporation | $36.73 | 2024-2025 | Cologuard Collection Kit |
| Merck Sharp & Dohme LLC | $29.78 | 2021 | |
| Dynavax Technologies Corporation | $25.71 | 2024 | Heplisav-B |
| Eisai INC. | $25.69 | 2021 | |
| Otsuka America Pharmaceutical, INC. | $24.35 | 2021 | |
| Pfizer INC. | $22.25 | 2024 | |
| Neos Therapeutics, LP | $19.48 | 2023 | Adzenys Xr-Odt |
| Optinose US, INC. | $18.23 | 2021 | |
| Xeris Pharmaceuticals, INC. | $15.80 | 2024 | Gvoke Hypopen |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $14.14 | 2021 | |
| Amgen INC. | $13.31 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $12.80 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Maya Mehta listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.